Ornim Medical closes $20m in its series B round from OrbiMed Advisors and General Electric.
Israel-based biotech firm Ornim Medical has attracted $20m in its series B round led by healthcare venture capital firm OrbiMed Advisors with participation from US-listed industrial conglomerate General Electric, which will be supplying financing through its corporate venturing GE Healthymagination fund.
GE’s Healthymagination is a $250m equity fund that makes investments in healthcare technology companies, and is managed both by GE Capital and GE Healthcare. GE Healthcare will be exploring a potential strategic relationship with Ornim.
Agate Medical Investment, an…
